Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis
暂无分享,去创建一个
M. Hudson | M. Baron | V. Sundararajan | Mianbo Wang | S. Proudman | N. Ferdowsi | M. Nikpour | W. Stevens | D. Prior | M. Huq | C. Rabusa | Tien Tay | J. Burchell | Sam Mancuso | Jodie L. Burchell